Further diseases involving the IL-17C/RE axis include psoriasiform skin lesions in inflammatory bowel disease (IBD) patients under anti-TNF-α treatment (53), recurrent aphthous ulcers (20), LPS-induced endotoxin shock (52), and different forms of cancer (38, 54–56) (Tables 2, 3). Here, IL17C is linked to cancer.